Barry A. Murrer

3.9k total citations
50 papers, 3.3k citations indexed

About

Barry A. Murrer is a scholar working on Oncology, Organic Chemistry and Materials Chemistry. According to data from OpenAlex, Barry A. Murrer has authored 50 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 21 papers in Organic Chemistry and 12 papers in Materials Chemistry. Recurrent topics in Barry A. Murrer's work include Metal complexes synthesis and properties (27 papers), Ferrocene Chemistry and Applications (10 papers) and Lanthanide and Transition Metal Complexes (8 papers). Barry A. Murrer is often cited by papers focused on Metal complexes synthesis and properties (27 papers), Ferrocene Chemistry and Applications (10 papers) and Lanthanide and Transition Metal Complexes (8 papers). Barry A. Murrer collaborates with scholars based in United Kingdom, United States and Germany. Barry A. Murrer's co-authors include Michael J. Abrams, Kenneth R. Harrap, Lloyd R. Kèlland, Prakash Mistry, Lloyd R. Kelland, C. F. J. Barnard, Phyllis M. Goddard, Florence I. Raynaud, John M. Brown and G Abel and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Barry A. Murrer

49 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barry A. Murrer United Kingdom	30	1.9k	1.3k	794	779	438	50	3.3k
José Pérez Spain	32	1.4k 0.7×	1.6k 1.3×	442 0.6×	613 0.8×	737 1.7×	165	3.4k
Philip C. Sharpe Australia	24	1.7k 0.9×	1.0k 0.8×	367 0.5×	811 1.0×	631 1.4×	40	2.8k
Simon P. Fricker United Kingdom	31	2.8k 1.5×	1.1k 0.9×	534 0.7×	1.2k 1.6×	446 1.0×	81	4.9k
Mauro Ravera Italy	33	1.7k 0.9×	1.7k 1.3×	585 0.7×	836 1.1×	413 0.9×	144	3.1k
Virginia H. Mansour United States	9	2.5k 1.3×	1.8k 1.4×	538 0.7×	1.1k 1.4×	373 0.9×	13	3.5k
Nicolai Burzlaff Germany	28	787 0.4×	1.0k 0.8×	367 0.5×	641 0.8×	936 2.1×	98	2.5k
Christian R. Kowol Austria	37	3.1k 1.7×	2.2k 1.7×	693 0.9×	1.3k 1.7×	839 1.9×	109	4.8k
Christen M. Giandomenico United States	16	1.7k 0.9×	1.5k 1.2×	389 0.5×	600 0.8×	383 0.9×	19	2.4k
James D. Hoeschele United States	27	1.9k 1.0×	1.3k 1.0×	460 0.6×	833 1.1×	443 1.0×	65	2.9k
Shin Aoki Japan	40	1.1k 0.6×	1.7k 1.3×	1.6k 2.0×	1.7k 2.2×	453 1.0×	167	4.9k

Countries citing papers authored by Barry A. Murrer

Since Specialization

Citations

This map shows the geographic impact of Barry A. Murrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry A. Murrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry A. Murrer more than expected).

Fields of papers citing papers by Barry A. Murrer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry A. Murrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry A. Murrer. The network helps show where Barry A. Murrer may publish in the future.

Co-authorship network of co-authors of Barry A. Murrer

This figure shows the co-authorship network connecting the top 25 collaborators of Barry A. Murrer. A scholar is included among the top collaborators of Barry A. Murrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry A. Murrer. Barry A. Murrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Qi, Guodong, Thomas E. Davies, Ali Nasrallah, et al.. (2022). Au-ZSM-5 catalyses the selective oxidation ofCH4 to CH3OH andCH3COOH using O2. Nature Catalysis. 5(1). 45–54. 174 indexed citations

2.

Grigg, Ronald, C.A. Kilner, Meena Senthilnanthanan, et al.. (2006). Cyclometallated Ir(III), Rh(III) and Ru(II) complexes as catalysts for the cyclotrimerisation of 1,6-diynes with monoynes. ARKIVOC. 2007(11). 145–160. 2 indexed citations

3.

Moreau, Christelle, Christopher G. Frost, & Barry A. Murrer. (1999). Catalytic asymmetric hydrosilylation of ketones using mixed-ligand ruthenium complexes. Tetrahedron Letters. 40(30). 5617–5620. 20 indexed citations

4.

Sharp, Swee Y., et al.. (1998). In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473. British Journal of Cancer. 77(3). 366–373. 172 indexed citations

5.

Raynaud, Florence I., et al.. (1998). Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro(2-methylpyridine)] platinum(II) (AMD473).. PubMed. 13(1). 1–18. 99 indexed citations

6.

Sharma, H.L., et al.. (1997). The synthesis of 191Pt labelled JM216, an orally active platinum anti-tumour agent. Applied Radiation and Isotopes. 48(4). 469–476. 2 indexed citations

7.

McKeage, Mark J., Florence I. Raynaud, Janet Ward, et al.. (1997). Phase I and pharmacokinetic study of an oral platinum complex given daily for 5 days in patients with cancer.. Journal of Clinical Oncology. 15(7). 2691–2700. 82 indexed citations

8.

Raynaud, Florence I., Prakash Mistry, Grace K. Poon, et al.. (1996). Biotransformation of the platinum drug JM216 following oral administration to cancer patients. Cancer Chemotherapy and Pharmacology. 38(2). 155–162. 103 indexed citations

9.

Kelland, Lloyd R., I. G. Evans, Barry A. Murrer, et al.. (1995). Synthesis and in Vitro and in Vivo Antitumor Activity of a Series of Trans Platinum Antitumor Complexes. Journal of Medicinal Chemistry. 38(16). 3016–3024. 74 indexed citations

10.

Mellish, Kirste, et al.. (1995). DNA‐binding properties of novel cis‐ and trans platinum‐based anticancer agents in 2 human ovarian carcinoma cell lines. International Journal of Cancer. 62(6). 717–723. 71 indexed citations

11.

Poon, Grace K., Florence I. Raynaud, Prakash Mistry, et al.. (1995). Metabolic studies of an orally active platinum anticancer drug by liquid chromatography-electrospray ionization mass spectrometry. Journal of Chromatography A. 712(1). 61–66. 44 indexed citations

12.

Neidle, Stephen, et al.. (1995). Bis(acetato)amminedichloro(cyclohexylamine)platinum(IV), an Orally Active Anticancer Drug. Acta Crystallographica Section C Crystal Structure Communications. 51(5). 822–824. 24 indexed citations

13.

McKeage, Mark J., Prakash Mistry, Janet Ward, et al.. (1995). A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administration. Cancer Chemotherapy and Pharmacology. 36(6). 451–458. 84 indexed citations

14.

McKeage, Mark J., Prakash Mistry, Janet Ward, et al.. (1995). A phase I and pharmacology study of an oral platinum complex, JM216: dose-dependent pharmacokinetics with single-dose administration. Cancer Chemotherapy and Pharmacology. 36(6). 451–458. 2 indexed citations

15.

Kèlland, Lloyd R., C. F. J. Barnard, Kirste Mellish, et al.. (1994). A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.. PubMed. 54(21). 5618–22. 116 indexed citations

16.

McKeage, Mark J., et al.. (1994). Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylates. Cancer Chemotherapy and Pharmacology. 33(6). 497–503. 17 indexed citations

17.

Orr, Rosanne M., CF O'Neill, MC Nicolson, et al.. (1994). Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin. British Journal of Cancer. 70(3). 415–420. 17 indexed citations

18.

Abrams, Michael J. & Barry A. Murrer. (1993). Metal Compounds in Therapy and Diagnosis. Science. 261(5122). 725–730. 237 indexed citations

19.

Kelland, Lloyd R., Mervyn Jones, Phyllis M. Goddard, et al.. (1991). Platinum coordination complexes which circumvent cisplatin resistance. Advances in Enzyme Regulation. 31. 31–43. 17 indexed citations

20.

Haines, Alan H., Christopher P. Morley, & Barry A. Murrer. (1989). Analogs of cisplatin derived from diaminodideoxytetritols. Synthesis and activity against the ADJ/PC6 plasmacytoma in mice. Journal of Medicinal Chemistry. 32(4). 742–745. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact